REQUEST A DEMO
Total
USD $0.00
Search more companies

Unilabs Pathology K.S. (Czech Republic)

Main Activities: Outpatient Care Centers | All Other Ambulatory Health Care Services
Secondary Activities: Other Miscellaneous Nondurable Goods Merchant Wholesalers | Materials Recovery Facilities
Full name: Unilabs Pathology K.S. Profile Updated: August 13, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English Download a sample report

Unilabs Pathology K.S. is a company based in Czech Republic, with its head office in Prague. The enterprise operates in the Outpatient Care Centers industry. It was first established on September 15, 1993. It currently has a total number of 200 - 249 (2023) employees. From the latest financial highlights, Unilabs Pathology K.S. reported a net sales revenue increase of 12.6% in 2024. Its’ total assets recorded a growth of 13.45%. Unilabs Pathology K.S.’s net profit margin decreased by 0.03% in 2024.

Headquarters
Evropska 2589/33
Prague; The City of Prague; Postal Code: 16000

Contact Details: Purchase the Unilabs Pathology K.S. report to view the information.

Basic Information
Total Employees:
Purchase the Unilabs Pathology K.S. report to view the information.
Financial Auditors:
Purchase the Unilabs Pathology K.S. report to view the information.
Incorporation Date:
September 15, 1993
Key Executives
Purchase this report to view the information.
Unlimited partner
Subsidiaries
Centrum Onkologicke Prevence Pro Zeny, S.R.O.
100%
Company Performance
Financial values in the chart are available after Unilabs Pathology K.S. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency CZK. Absolute financial data is included in the purchased report.
Net sales revenue
12.6%
Total operating revenue
12.2%
Operating profit (EBIT)
13.66%
EBITDA
12.68%
Net Profit (Loss) for the Period
5.36%
Total assets
13.45%
Total equity
5.98%
Operating Profit Margin (ROS)
0.36%
Net Profit Margin
-0.03%
Return on Equity (ROE)
-0.03%
Quick Ratio
0.06%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?